Podiatrists in Homewood, AL Accepting Medicare
2 Podiatrists found. Showing 1 - 2
 Dr.david Roberson Jr.dpm Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 840 Oak Grove Rd, Homewood, AL 35209 Phone: 205-942-0514 Fax: 205-942-8523 |
 Dr. David Roberson Ii, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 840 Oak Grove Rd, Homewood, AL 35209 Phone: 205-942-0514 Fax: 205-942-8523 |
News Archive
New partnership aims to create stem cell resource to study psychiatric disorders
The New York Stem Cell Foundation and the Stanley Center at the Broad Institute of MIT and Harvard are partnering to create a foundational stem cell resource to study psychiatric disorders through the production of induced pluripotent stem (iPS) cell lines from individuals with schizophrenia and other psychiatric disorders.
Massive weight loss conference hits Dallas
While massive weight loss surgery is increasingly becoming the treatment of choice for the morbidly obese, many patients are unaware that additional plastic surgery – body contouring – will likely be necessary to achieve their desired body shape.
Genentech receives FDA approval for Erivedge to treat basal cell carcinoma
Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body.
Salk scientists uncover enzyme responsible for suppressing deadly lung cancer
Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.
Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the breast cancer drug market in Brazil will grow from $424 million in 2009 to $611 million in 2014. Factors promoting the market's growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.
› Verified 7 days ago
Physical Therapists
Chiropractors
Optometrists
Speech-Language Pathologists
Occupational Therapists
Audiologists
Podiatrists